17996-13-3

Basic information

• Product Name: 4-(Z-AMINO)-1-BUTANOL
• Synonyms: 4-(Z-AMINO)-1-BUTANOL;BENZYL N-(4-HYDROXYBUTYL)CARBAMATE;N-CARBOBENZOXY-DELTA-AMINO-N-BUTYL ALCOHOL;N-CARBOBENZOXY-4-AMINO-1-BUTANOL;Z-ABU(4)-OL;Z-NH-(CH2)4-OH;4-N-CBZ-AMINO-BUTAN-1-OL ;(4-Hydroxy-butyl)-carbamic acid benzyl ester
• CAS NO: 17996-13-3
• Molecular Formula: C₁₂H₁₇NO₃
• Molecular Weight: 223.27
• Mol File: 17996-13-3.mol

Chemical Properties

• Melting Point: 81-84 °C
• Boiling Point: 397.1°Cat760mmHg
• Flash Point: 193.9°C
• Appearance: /
• Density: 1.127
• Vapor Pressure: 5.12E-07mmHg at 25°C
• Refractive Index: 1.53
• BRN: 2214428
• CAS DataBase Reference: 4-(Z-AMINO)-1-BUTANOL(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(Z-AMINO)-1-BUTANOL(17996-13-3)
• EPA Substance Registry System: 4-(Z-AMINO)-1-BUTANOL(17996-13-3)

Safety Data

• Hazard Codes: Xn
• Statements: 22-36
• Safety Statements: 26
• WGK Germany: 3
• Hazardous Substances Data: 17996-13-3(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical and Agrochemical Synthesis:
4-(Z-AMINO)-1-BUTANOL is used as a key intermediate in the synthesis of various pharmaceuticals and agrochemicals. Its unique structure allows for the creation of chiral molecules, which are essential in the development of drugs with specific biological activities.
Used in Surfactant Production:
In the chemical industry, 4-(Z-AMINO)-1-BUTANOL is utilized in the production of surfactants, which are critical components in a wide range of consumer products, including detergents, soaps, and personal care items. Its ability to form stable emulsions and its compatibility with various substances make it a valuable ingredient in surfactant formulations.
Used in Specialty Chemicals:
4-(Z-AMINO)-1-BUTANOL also finds application in the production of specialty chemicals, where its unique properties can be leveraged to create compounds with specific functions or improved performance characteristics.
Used as a Chiral Auxiliary in Asymmetric Synthesis:
Due to its chiral center and Z-configuration, 4-(Z-AMINO)-1-BUTANOL is employed as a chiral auxiliary in asymmetric synthesis reactions. This application is crucial for the production of enantiomerically pure compounds, which are often required in the pharmaceutical industry to ensure the desired biological activity and to avoid potential side effects associated with the less active or unwanted enantiomer.

InChI:InChI=1/C12H17NO3/c14-9-5-4-8-13-12(15)16-10-11-6-2-1-3-7-11/h1-3,6-7,14H,4-5,8-10H2,(H,13,15)

Upstream product

• 13325-10-5 4-Aminobutanol 
• 137160-76-0 acetone O-(benzyloxycarbonyl)oxime 
• 67706-63-2 4-benzyloxycarbonylaminobutyric acid methyl ester 
• 501-53-1 benzyl chloroformate 
• 13139-17-8 N-(Benzyloxycarbonyloxy)succinimide 
• 14468-80-5 N-benzyloxycarbonylpyrrolidin-2-one 
• 1346132-49-7 C₂₈H₃₅NO₃Si 

Downstream Products

• 69037-98-5 4-[(benzyloxycarbonyl)amino]butyric aldehyde 
• 123348-73-2 4-azido-N-benzyloxycarbonyl-1-butylamine 
• 174626-26-7 N-(benzyloxycarbonyl)-O-(methanesulfonyl)aminobutanol 
• 101625-10-9 N-[(phenylmethoxy)carbonyl]-4-bromobutylamine 
• 476447-08-2 N¹,N⁵,N¹⁰-tri-tert-butoxycarbonyl-N¹⁹-benzyloxycarbonyl-1,5,10,14,19-pentaazanonadecane 
• 447408-48-2 ((Z)-5-Iodo-pent-4-enyl)-carbamic acid benzyl ester 
• 118743-82-1 N-<4-(Benzyloxycarbonylamino)butylidene>-(R)-(-)-α-methylbenzylamine N-oxide 
• 118743-76-3 3(R)-(4-Benzyloxycarbonylaminobutyl)-N-<(R)-(-)-α-methylbenzyl>isoxazolidin-5-ol 
• 118743-76-3 3(S)-(4-Benzyloxycarbonylaminobutyl)-N-<(R)-(-)-α-methylbenzyl>isoxazolidin-5-ol 
• 118743-78-5 (3R)-(4-Benzyloxycarbonylaminobutyl)-N-<(R)-(-)-α-methylbenzyl>isoxazolidin-5-one 
• 118743-79-6 (3S)-(4-Benzyloxycarbonylaminobutyl)-N-<(R)-(-)-α-methylbenzyl>isoxazolidin-5-one 
• 118743-83-2 5-Acetoxy-3(R)-(4-benzyloxycarbonylaminobutyl)-N-<(R)-(-)-α-methylbenzyl>isoxazolidine 
• 118743-83-2 5-Acetoxy-3(S)-(4-benzyloxycarbonylaminobutyl)-N-<(R)-(-)-α-methylbenzyl>isoxazolidine 
• 73352-51-9 N-(4-benzyloxycarbonylaminobutyloxycarbonyloxy)sucinimide 

Relevant articles and documents

DEUTERATED FORMS OF AMINOSTEROLS AND METHODS OF USING THE SAME

Described are deuterated forms of aminosterols, or a pharmaceutically acceptable salt thereof, wherein one or more hydrogen atoms at one or more positions selected from C1, C2, C3, C4, C5, C6, C7, C8, C9, C11, C12, C14, C15, C16, C17, C18, C19, C20, C21,

IMIDAZOQUINOLINE AMINE DERIVATIVES, PHARMACEUTICAL COMPOSITION, USE THEREOF

The invention provides novel imidazoquinoline amine derivatives, having agonistic activities to Toll-like receptors (TLRs), in particular TLR7 and/or TLR8, pharmaceutical compositions thereof, and methods of treatment, reduction or prevention of certain d

Synthesis method of double different protected amino acids

The invention relates to a synthesis method of double different protected amino acids.The technical problems of harsh reaction conditions, inapplicability of production enlarging and the like in an existing synthesis method are mainly solved. According to the technical scheme, the synthesis method of double different protected amino acids comprises the following steps: one of Boc20, Alloc-Cl or Cbz-Osuis added to amino alcohol under the action of an alkaline reagent to obtain a compound 1; the compound 1 reacts with methanesulfonyl chloride or paratoluensulfonyl chloride to obtain an intermediate, then a halide is added into acetone, heating and refluxing are executed to obtain a compound 2; the compound 2 is condensed with diethyl acetamidomalonate under the action of an alkaline agent togenerate a compound 3; the compound 3 is dissolved in alcohol and water, an inorganic base is added, heating, hydrolyzing and decarboxylating are executed to obtain a compound 4; acetylase is added into deionized water to obtain a compound 5 through enzymolysis; amino acid protection is executed, wherein one of Fmoc-Osu, Cbz-OSu, Alloc-Cl or Boc20 is added into thecompound 5 under the action of an alkaline agent to generatea target compound A.

Rapid Assembly of Saturated Nitrogen Heterocycles in One-Pot: Diazo-Heterocycle “Stitching” by N–H Insertion and Cyclization

Methods that provide rapid access to new heterocyclic structures in biologically relevant chemical space provide important opportunities in drug discovery. Here, a strategy is described for the preparation of 2,2-disubstituted azetidines, pyrrolidines, pi

CYCLIC KETO-AMIDE COMPOUNDS AS CALPAIN MODULATORS AND METHODS OF PRODUCTION AND USE THEREOF

The present technology relates to cyclic keto-amide compounds of general formulae I to XXXII, compositions and kits thereof as calpain modulators and methods useful for the treatment of various diseases or disorders such as fibrotic disease or cancer whic

HEPATITIS B CORE PROTEIN ALLOSTERIC MODULATORS

ABSTRACT The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.

Magnetic beads having surface glycoconjugates and use thereof

Magnetic beads that include polyvalent ligands comprising various carbohydrates are described. Methods for fabricating such magnetic beads are also provided as well as methods of their use to capture and enrich pathogen cell population for subsequent culture, lysis and identification.

OLIGONUCLEOTIDE-LIGAND CONJUGATES AND PROCESS FOR THEIR PREPARATION

The present invention relates to ligand conjugates of oligonucleotides (e.g., iRNA agents) and methods for their preparation. The ligands are derived primarily from monosaccharides These conjugates are useful for the in vivo delivery of oligonucleotides.

LIPIDATED IMMUNE RESPONSE MODIFIER COMPOUND COMPOSITIONS, FORMULATIONS, AND METHODS

The compound N-(4-{[4-amino-2-butyl-1H-imidazo[4,5-c]quinolin-1-yl]oxy}butyl)octadecanamide is a useful drug compound for enhancing immune response and can be used, for example, as a vaccine adjuvant and a cancer treatment.

Asymmetric organocatalytic intramolecular aza-michael addition of enone carbamates: Catalytic enantioselective access to functionalized 2-substituted piperidines

The synthetically useful functionalized 2-substituted piperidines containing a lateral ketone group have been strategically accessed via an organocatalytic enantioselective intramolecular aza-Michael addition of enone carbamates, in which a novel internal substrate combination of the enone moiety as Michael acceptor and the carbamate moiety as Michael donor was revealed in asymmetric bifunctional organocatalysis. This heteroatom conjugate addition, which was realized by using a catalytic chiral Cinchona-based primary-tertiary diamine and an achiral Bronsted acid, mostly proceeded in high yield and good to excellent stereocontrol (up to 99% ee). This reaction provides an alternative catalytic asymmetric method for installing the stereogenic nitrogen-containing carbon center in functionalized 2-substituted piperidines, leading to the development of a straightforward and expeditious synthesis of some naturally occurring bioactive 2-substituted piperidine alkaloids. Copyright